Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 11-2012 | 08-2012 | 05-2012 | 02-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 5,547 | 4,447 | 1,316 | 1,840 |
| Marketable Securities | N/A | 1,065 | 655 | 857 | 1,180 |
| Receivables | N/A | 177 | 173 | 264 | 75 |
| TOTAL | $N/A | $6,808 | $5,277 | $2,459 | $3,108 |
| Non-Current Assets | |||||
| PPE Net | N/A | 3 | 5 | 2 | 8 |
| Investments And Advances | 0 | 9 | 9 | 9 | 9 |
| Other Non-Current Assets | 0 | 5 | 5 | 5 | 17 |
| TOTAL | $N/A | $17 | $18 | $16 | $34 |
| Total Assets | $N/A | $6,825 | $5,295 | $2,474 | $3,143 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 335 | 644 | 356 | 582 |
| TOTAL | $N/A | $335 | $644 | $356 | $582 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 240 | 872 | 147 | 162 |
| TOTAL | $N/A | $240 | $872 | $147 | $162 |
| Total Liabilities | $N/A | $575 | $1,517 | $503 | $744 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,505 | 86,505 | N/A | 70,454 | 70,321 |
| Common Shares | N/A | 87 | 80 | 70 | 70 |
| Retained earnings | N/A | -18,851 | -17,892 | -16,562 | -16,011 |
| Other shareholders' equity | 0 | 236 | 0 | 16 | 0 |
| TOTAL | $N/A | $6,250 | $3,778 | $1,972 | $2,398 |
| Total Liabilities And Equity | $0 | $6,825 | $5,295 | $2,474 | $3,143 |